Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held today at 10:45 am and concluded at 12:20 pm, inter-alia, approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2019. We enclose copies of the following: 1.Unaudited Financial Results for the quarter ended June 30, 2019; and 2.Limited Review Report for Unaudited Financial Results for the said period. We request you to take the same on record.

Pdf Link: Welcure Drugs & Pharmaceuticals Ltd. - Financial Results For The Quarter Ended 30.06.2019

Source : BSE - www.bseindia.com

comment COMMENT NOW